- Bradykinin receptor
protein
Name =bradykinin receptor B1
caption =
width =
HGNCid = 1029
Symbol = BDKRB1
AltSymbols =
EntrezGene = 623
OMIM = 600337
RefSeq = NM_000710
UniProt = P46663
PDB =
ECnumber =
Chromosome = 14
Arm = q
Band = 32.1
LocusSupplementaryData = -32.2protein
Name =bradykinin receptor B2
caption =
width =
HGNCid = 1030
Symbol = BDKRB2
AltSymbols =
EntrezGene = 624
OMIM = 113503
RefSeq = NM_000623
UniProt = P30411
PDB =
ECnumber =
Chromosome = 14
Arm = q
Band = 32.1
LocusSupplementaryData = -32.2The bradykinin receptor is a receptor forbradykinin .There are two Bradykinin receptors: the B1 receptor and the B2 receptor.cite journal | author = Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL | title = International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences | journal = Pharmacol. Rev. | volume = 57 | issue = 1 | pages = 27–77 | year = 2005 | pmid = 15734727 | doi = 10.1124/pr.57.1.2 | issn = ]
B2 receptor
The B2 receptor is a
G protein-coupled receptor , coupled to Gq and Gi. Gq stimulatesphospholipase C to increaseintracellular freecalcium and Gi inhibitsadenylate cyclase . Furthermore, the receptor stimulates themitogen-activated protein kinase pathways. It is ubiquitously and constitutively expressed in healthy tissues.The B2 receptor forms a complex with angiotensin converting enzyme (ACE), and this is thought to play a role in cross-talk between the renin-angiotensin system (RAS) and the kinin-kallikrein system (KKS). The heptapeptide angiotensin 1-7 (A1-7) also potentiates bradykinin action on B2 receptors.cite journal | author = Fernandes L, Fortes ZB, Nigro D, Tostes RC, Santos RA, Catelli De Carvalho MH | title = Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo | journal = Hypertension | volume = 37 | issue = 2 Part 2 | pages = 703–9 | year = 2001 | pmid = 11230360 | doi = | issn = | url = http://hyper.ahajournals.org/cgi/content/abstract/37/2/703 ]
Ictibant is a second generation B2 receptor antagonist which has undergone limited clinical trials in pain and inflammation.
Kallidin also signals through the B2 receptor.References
External links
* [http://www.iuphar-db.org/GPCR/ChapterMenuForward?chapterID=1330 IUPHAR GPCR Database - Bradykinin Receptor family]
*
Wikimedia Foundation. 2010.